Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats

Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Selim Cellek , Neale A. Foxwell and Salvador Moncada From the Wolfson Institute for Biomedical Research, University College London, London, U.K Address correspondence and reprint requests to Dr. Selim Cellek, Wolfson Institut...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 52; no. 9; pp. 2353 - 2362
Main Authors CELLEK, Selim, FOXWELL, Neale A, MONCADA, Salvador
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Diabetes Association 01.09.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two Phases of Nitrergic Neuropathy in Streptozotocin-Induced Diabetic Rats Selim Cellek , Neale A. Foxwell and Salvador Moncada From the Wolfson Institute for Biomedical Research, University College London, London, U.K Address correspondence and reprint requests to Dr. Selim Cellek, Wolfson Institute for Biomedical Research, University College London, Gower Street, Cruciform Building, London, WC1E 6BT, U.K. E-mail: s.cellek{at}ucl.ac.uk Abstract The distinction between metabolic and structural changes occurring in autonomic neurons during diabetes has not been fully clarified. Here we demonstrate that nitric oxide synthase-containing (nitrergic) neurons innervating the penis and gastric pylorus of streptozotocin-induced diabetic rats undergo a selective degenerative process in two phases. In the first phase, nitrergic nerve fibers lose some of their neuronal nitric oxide synthase content and function. In the second phase, nitrergic degeneration takes place in the cell bodies in the ganglia, leading to complete loss of nitrergic function. The changes in the first phase are reversible with insulin replacement; however, the neurodegeneration in the second phase is irreversible. Neurodegeneration is due to apoptotic cell death in the ganglia, which is selective for the nitrergic neurones. AGE, advanced glycation end product ChAT, choline acetyl transferase EFS, electrical field stimulation eNOS, endothelial nitric oxide synthase iNOS, inducible nitric oxide synthase l-NAME, NG-nitro-l-arginine methyl ester MPG, major pelvic ganglion NANC, nonadrenergic noncholinergic NOS, nitric oxide synthase nNOS, neuronal nitric oxide synthase ROS, reactive oxygen species sGC, soluble guanylyl cyclase SP, substance P STZ, streptozotocin TH, tyrosine hydroxylase TTX, tetrodotoxin TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling VAChT, vesicular acetylcholine transporter VIP, vasoactive intestinal peptide Footnotes Accepted May 29, 2003. Received March 3, 2003. DIABETES
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0012-1797
1939-327X
DOI:10.2337/diabetes.52.9.2353